Innate Pharma (IPHA) FCF Margin (2019 - 2025)
Innate Pharma's (IPHA) quarterly FCF Margin came in at 5.02% in Q4 2025, up 193.0% YoY from 1.71% in Q4 2024, and up 62.16% on a QoQ basis from 3.1% in Q4 2024.
Innate Pharma (IPHA) FCF Margin (2019 - 2025) Analysis & Trends
Innate Pharma (IPHA) has 7 years of FCF Margin data on file, last reported at 5.02% in Q4 2025.
- Quarterly FCF Margin rose 193.0% year-over-year to 5.02% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.09% (up 14.0% YoY) and the FY2025 annual result came in at 587.4%, down 55118.0% from the prior year.
- FCF Margin climbed to 5.02% in Q4 2025, from 3.1% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 7.67% in Q4 2021 to a low of 0.0% in Q4 2022.
- A 5-year average of 2.49% and a median of 1.89% in 2023 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2021 — FCF Margin soared 605 bps — and 2022, when it tumbled 767 bps.
- Tracing IPHA's FCF Margin over 5 years: stood at 7.67% in 2021, then slumped by 100 bps to 0.0% in 2022, then jumped by 62574 bps to 0.68% in 2023, then jumped by 358 bps to 3.1% in 2024, then jumped by 62 bps to 5.02% in 2025.
- The last three FCF Margin figures came in at 5.02% (Q4 2025), 3.1% (Q4 2024), and 3.41% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 70.82% |
| 10 | Innate Pharma | 202.03 Mn | 202.03 Mn | - | -1,887.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.02% |
| Dec 31, 2024 | 3.10% |
| Jun 30, 2024 | 3.41% |
| Dec 31, 2023 | 0.68% |
| Jun 30, 2023 | 0.01% |
| Dec 31, 2022 | 0.00% |
| Jun 30, 2022 | 0.01% |
| Dec 31, 2021 | 7.67% |
| Dec 31, 2020 | 1.62% |
| Dec 31, 2019 | 1.84% |